Low dose methods for treating disorders in which TNF-alpha activity is detrimental

Low dose methods for treating disorders in which TNF-alpha activity is detrimental

  • CN 1,732,015 A
  • Filed: 10/24/2003
  • Published: 02/08/2006
  • Est. Priority Date: 10/24/2002
  • Status: Active Application
First Claim
Patent Images

1. be used for the treatment of wherein that the TNF alpha active is the method for deleterious disease, comprise sufferer is used the TNF alpha inhibitor of effective dose of low dose therapy to treat this disease.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×